Clinical trial
Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
NCT00305578 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00305578 |
|---|---|
| Title | Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression |
| Official title | Memantine Augmentation of Lamotrigine Incomplete Response in Bipolar Depression: A Randomized Placebo Controlled Clinical Trial |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Depression |
| Intervention type | Drug |
| Interventions | Memantine, Placebo |
| Enrollment | 29 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Mar 22, 2006 |
| Last update posted | Jul 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: